What each company builds, where it is based and how it has been funded. Search by name or by what the product does.
ReEmerge is developing Cognitive Network Restoration Therapy (CNRT) for people with chronic cognitive impairment after brain injury. The treatment targets underactive but viable neural circuits in the central thalamus to restore function across disrupted brain networks; the company is advancing this restorative approach through clinical development.
RegCell is developing cell therapies for autoimmune disease by epigenetically reprogramming pathogenic conventional T cells into stable regulatory T cells, aiming to restore immune tolerance without gene engineering; its platform is advancing toward clinical development.
Retham is developing HITDx, a functional hospital-lab assay for heparin-induced thrombocytopenia that uses stable cryopreserved donor platelets to make clinically relevant platelet testing more practical; the diagnostic is in validation and regulatory development, while its cryopreserved platelets are available for research use.
Samson Sky is developing the Switchblade, a two-seat roadable aircraft whose wings and tail fold for road travel and deploy for flight. The hybrid-electric vehicle has completed its first test flight, while the company continues flight testing and production engineering before customer deliveries.
Scaffold connects homebuilders, trade contractors and suppliers by ingesting job data from their existing portals and systems, then normalizing purchase orders, schedules and job records into a shared operating layer that automates coordination across residential construction projects.
AI agents that automate software testing and help teams improve application quality.
Modular plants that convert renewable electricity into synthetic methane.
Vantage develops and operates high-capacity data centers for cloud and AI companies.
Velocity provides stablecoin settlement and treasury infrastructure for businesses and financial institutions.